Eluryng

Active Ingredient(s): Ethinyl Estradiol + Etonogestrel
FDA Approved: * December 11, 2019
Pharm Company: * AMNEAL PHARMS LLC
Category: Birth Control / Contraceptive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Eluryng Overview

Ethinylestradiol/etonogestrel, sold under the brand names NuvaRing among others, is a hormonal vaginal ring used for birth control and to improve menstrual symptoms.[1] It contains ethinylestradiol, an estrogen, and etonogestrel, a progestin.[2] It is used by insertion into the vagina.[1] Pregnancy occurs in about 0.3% of women with perfect use and 9% of women with typical use.[3] Common side effects include irregular vaginal ble...

Read more Eluryng Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/NuvaRing

Recent Eluryng Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ethinyl Estradiol + Etonogestrel
  • Insert, Extended Release: 0.015mg/day + 0.12mg/day
  • Ring: 0.015mg + 0.12mg, 0.015mg/24hr + 0.12mg/24hr
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Eluryng: (1 result)

Sorted by National Drug Code
  • 65162-469 Eluryng Vaginal Ring by Amneal Pharmaceuticals LLC

Drugs with one or more similar ingredients: (209 results)